Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome.

[1]  M. Sabatine,et al.  Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. , 2010, Journal of the American College of Cardiology.

[2]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[3]  Tobias Reichlin,et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.

[4]  R. Niska,et al.  National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. , 2008, National health statistics reports.

[5]  F. Apple,et al.  Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. , 2008, Clinical chemistry.

[6]  C. Hamm,et al.  N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. , 2008, Journal of the American College of Cardiology.

[7]  D. Morrow,et al.  Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. , 2007, American journal of clinical pathology.

[8]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[9]  Eric W Nawar,et al.  National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. , 2007, Advance data.

[10]  F. Botto,et al.  Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. , 2004, European heart journal.

[11]  A. Wu,et al.  Evaluation of imprecision for cardiac troponin assays at low-range concentrations. , 2004, Clinical chemistry.

[12]  K. Thygesen,et al.  Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .

[13]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[14]  H. White,et al.  Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban , 1999, The Lancet.

[15]  C. Heeschen,et al.  Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. , 1999, The New England journal of medicine.

[16]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[17]  B. Lindahl,et al.  Clinical performance of two highly sensitive cardiac troponin I assays. , 2009, Clinical Chemistry.

[18]  W. Wodzig,et al.  Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. , 2009, Clinical chemistry.

[19]  Joseph S Alpert,et al.  [Universal definition of the myocardial infarction]. , 2008, Kardiologia polska.